What are the side effects of targeted therapy for liver cancer? 3 side effects of targeted therapy for liver cancer

The side effects of targeted therapy for liver cancer generally include hand-foot syndrome, severe diarrhea, liver and kidney damage, etc.

1. Hand-foot syndrome:

Patients with liver cancer who receive long-term targeted therapy may develop hand-foot syndrome, which causes the skin on the hands and feet to peel and harden, accompanied by herpes, pain, etc. This hand-foot syndrome can be treated with medications such as diclofenac diethylamine emulsion and urea ointment as prescribed by the doctor to relieve symptoms.

2. Severe diarrhea:

Liver cancer patients who undergo long-term targeted therapy may also experience severe diarrhea, nausea and vomiting due to drug stimulation. In this case, they should stop taking medication, adjust their diet, focus on light and easily digestible foods, and pay attention to balanced nutrition.

3. Liver and kidney damage:

Liver and kidney damage is also one of the side effects of targeted therapy for liver cancer. Since targeted drugs need to be broken down and excreted by the liver and kidneys, they will increase the burden on the liver and kidneys, causing patients to experience symptoms such as edema and fatigue. Targeted therapy should be stopped first, and liver-protecting drugs such as glutathione tablets and ursodeoxycholic acid capsules should be taken as prescribed by the doctor.